» Articles » PMID: 26170061

Lack of LCAT Reduces the LPS-neutralizing Capacity of HDL and Enhances LPS-induced Inflammation in Mice

Overview
Specialties Biochemistry
Biophysics
Date 2015 Jul 15
PMID 26170061
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

HDL has important immunomodulatory properties, including the attenuation of lipopolysaccharide (LPS)-induced inflammatory response. As lecithin-cholesterol acyltransferase (LCAT) is a critical enzyme in the maturation of HDL we investigated whether LCAT-deficient (Lcat(-/-)) mice present an increased LPS-induced inflammatory response. LPS (100μg/kg body weight)-induced cytokine response in Lcat(-/-) mice was markedly enhanced and prolonged compared to wild-type mice. Importantly, reintroducing LCAT expression using adenovirus-mediated gene transfer reverted their phenotype to that of wild-type mice. Ex vivo stimulation of whole blood with LPS (1-100ng/mL) showed a similar enhanced pro-inflammatory phenotype. Further characterization in RAW 264.7 macrophages in vitro showed that serum and HDL, but not chylomicrons, VLDL or the lipid-free protein fraction of Lcat(-/-) mice, had a reduced capacity to attenuate the LPS-induced TNFα response. Analysis of apolipoprotein composition revealed that LCAT-deficient HDL lacks significant amounts of ApoA-I and ApoA-II and is primarily composed of ApoE, while HDL from Apoa1(-/-) mice is highly enriched in ApoE and ApoA-II. ApoA-I-deficiency did not affect the capacity of HDL to neutralize LPS, though Apoa1(-/-) mice showed a pronounced LPS-induced cytokine response. Additional immunophenotyping showed that Lcat(-/-) , but not Apoa1(-/-) mice, have markedly increased circulating monocyte numbers as a result of increased Cd11b(+)Ly6C(med) monocytes, whereas 'pro-inflammatory' Cd11b(+)Ly6C(hi) monocytes were reduced. In line with this observation, peritoneal macrophages of Lcat(-/-) mice showed a markedly dampened LPS-induced TNFα response. We conclude that LCAT-deficiency increases LPS-induced inflammation in mice due to reduced LPS-neutralizing capacity of immature discoidal HDL and increased monocyte number.

Citing Articles

High-Density Lipoprotein Metabolism and Function in Cardiovascular Diseases: What about Aging and Diet Effects?.

Morvaridzadeh M, Zoubdane N, Heshmati J, Alami M, Berrougui H, Khalil A Nutrients. 2024; 16(5).

PMID: 38474781 PMC: 10935171. DOI: 10.3390/nu16050653.


Seasonal Factors Are Associated with Activities of Enzymes Involved in High-Density Lipoprotein Metabolism among Pregnant Females in Ghana.

Hong B, Zheng J, Romo E, Agus J, Tang X, Arnold C Curr Dev Nutr. 2023; 7(12):102041.

PMID: 38130330 PMC: 10733676. DOI: 10.1016/j.cdnut.2023.102041.


Dyslipidemia in rheumatoid arthritis: the possible mechanisms.

Yan J, Yang S, Han L, Ba X, Shen P, Lin W Front Immunol. 2023; 14:1254753.

PMID: 37954591 PMC: 10634280. DOI: 10.3389/fimmu.2023.1254753.


Candidate SNP Markers Significantly Altering the Affinity of TATA-Binding Protein for the Promoters of Human Hub Genes for Atherogenesis, Atherosclerosis and Atheroprotection.

Bogomolov A, Filonov S, Chadaeva I, Rasskazov D, Khandaev B, Zolotareva K Int J Mol Sci. 2023; 24(10).

PMID: 37240358 PMC: 10219026. DOI: 10.3390/ijms24109010.


ApoE Mimetic Peptides to Improve the Vicious Cycle of Malnutrition and Enteric Infections by Targeting the Intestinal and Blood-Brain Barriers.

Oria R, Freitas R, Roque C, Nascimento J, Paula Silva A, Malva J Pharmaceutics. 2023; 15(4).

PMID: 37111572 PMC: 10141726. DOI: 10.3390/pharmaceutics15041086.